Annual Meeting Of Association Research Articles

Emergency Skills in Athletic Training: Perceived Knowledge and Continuing Education

Context Continuing education (CE) in health care, particularly in athletic training, often fails to meet the needs of its participants. Rapid increases in available information make it necessary for CE to be delivered as efficiently as possible. Objective To explore whether an interactive teaching strategy and various characteristics of athletic trainers affected the perceived knowledge of emergency skills among certified athletic trainers. Design Quasiexperimental study with a single-group pretest-posttest design. Patients or Other Participants Certified athletic trainers (N = 81) at the Great Lakes Athletic Trainers' Association Annual Meeting and Symposium. Intervention(s) Emergency skills practice session for anaphylaxis, opioid overdose, diabetes, and asthma. Main Outcome Measure(s) Participants completed a preintervention perceived knowledge questionnaire (PKQ) that included background information questions and completed a postintervention PKQ. Results A statistically significant difference (P < .001) in PKQ scores from pretest to posttest was found with pretest scores being lower than posttest scores (89.59 and 103.02, respectively). Age and years of experience had a weak correlation with PKQ pretest scores (rs = .32 and rs = .33, respectively). Participant characteristics including additional certification (P = .012), anaphylaxis experience (P = .036), opioid overdose experience (P < .001), diabetes experience (P = .025), and combined emergency experience (P = .029) had significantly different pretest PKQ scores. Conclusions The use of an interactive teaching strategy in CE and certain athletic trainer characteristics significantly affected athletic trainers' perceived knowledge of emergency skills.

Awards Presented at the 53rd Annual Meeting of the Behavior Genetics Association, June 24 2023, Murcia, Spain.

Awards Presented at the 53rd Annual Meeting of the Behavior Genetics Association, June 24 2023, Murcia, Spain.

59th EASD Annual Meeting of the European Association for the Study of Diabetes : Hamburg, Germany, 2 - 6 October 2023.

59th EASD Annual Meeting of the European Association for the Study of Diabetes : Hamburg, Germany, 2 - 6 October 2023.

Characteristics of programmes designed to link community-dwelling older adults in high-income countries from community to clinical sectors: a scoping review protocol

IntroductionResearch on effectively navigating older adults into primary care is urgently needed. Community–clinic linkage models (CCLMs) aim to improve population health by linking the health and community sectors in order...

Proceedings of the 26th Annual Meeting of the Japanese Association for Biotherapeutics: 10 December 2022 Osaka, Japan.

Proceedings of the 26th Annual Meeting of the Japanese Association for Biotherapeutics: 10 December 2022 Osaka, Japan.

Abstracts from the 71st Annual Meeting of the British Thyroid Association

Abstracts from the 71st Annual Meeting of the British Thyroid Association

Hypertension Linked to Worse Upper Tract Urothelial Cancer Outcomes

Hypertension Linked to Worse Upper Tract Urothelial Cancer Outcomes

JU Open Plus: American Urological Association Annual Meeting 2023: Time With Our Science and the Mentors that Make It Happen

JU Open Plus: American Urological Association Annual Meeting 2023: Time With Our Science and the Mentors that Make It Happen

On The 64rd Annual Meeting of the Japanese Association of Educational Psychology

On The 64rd Annual Meeting of the Japanese Association of Educational Psychology

Review of the 38th Annual Meeting of the European Association of Urology (EAU) 2023

WELCOMED by the graceful vocals of the Italian Tenors, Christopher Chapple, European Association of Urology (EAU) Secretary General, opened what he described as a “vibrant programme” at the 38th Annual EAU Congress, held in Milan, Italy between the 10th-13th March 2023. Boasting a rich history of art, architecture, and culture, and home to Leonardo da Vinci’s famous mural ‘The Last Supper’, over this weekend Milan traded its role as a global hub for fashion and design to host the largest urology event in Europe.

The growing clinical effect of SGLT2 inhibitors

In September, 2015, the results of EMPA-REG OUTCOME, the first cardiovascular outcomes study based on a sodium-glucose co-transporter-2 (SGLT2) inhibitor, empagliflozin, were announced at the Annual Meeting of the European Association for the Study of Diabetes. It was the first of a series of cardiovascular outcome studies confirming a significant risk reduction of the three-point MACE (cardiovascular mortality, non-fatal myocardial infarction, and non-fatal stroke) in people with type 2 diabetes and established atherosclerotic cardiovascular disease. It was also the first clinical trial to show potential renal protection: empagliflozin was associated with reduced loss of estimate glomerular filtration rate compared with placebo. Moreover, the trial reported a significant reduction in the risk of hospitalisation for heart failure. 1 Zinman B Wanner C Lachin JM et al. Investigators E-ROEmpagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015; 373: 2117-2128 Crossref PubMed Scopus (7211) Google Scholar The cardiorenal protective effects of SGLT2 inhibitors have been confirmed in subsequent cardiovascular outcomes studies done in people with type 2 diabetes 2 McGuire DK Shih WJ Cosentino F et al. Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis. JAMA Cardiol. 2021; 6: 148-158 Crossref PubMed Scopus (339) Google Scholar and without diabetes. 3 Vaduganathan M Docherty KF Claggett BL et al. SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials. Lancet. 2022; 400: 757-767 Summary Full Text Full Text PDF PubMed Scopus (61) Google Scholar Because of these results, current guidelines recommend the use of a SGLT2 inhibitor with proven beneficial effect for people with type 2 diabetes with chronic kidney disease and a history of heart failure. 4 Davies MJ Aroda VR Collins BS et al. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2022; 65: 1925-1966 Crossref PubMed Scopus (32) Google Scholar Effects of dapagliflozin on hospitalisations in people with type 2 diabetes: post-hoc analyses of the DECLARE-TIMI 58 trialDapagliflozin reduced the risk of first and total non-elective hospitalisations for any cause in people with type 2 diabetes, regardless of the presence of atherosclerotic cardiovascular disease, including hospitalisations not directly attributed to cardiac, kidney, or metabolic causes. These findings might have implications on health-related quality of life for people with type 2 diabetes and on health-care costs attributable this condition. Full-Text PDF

Abstracts

Abstracts

Power of PTAIR 2.0 in Prediction, Identification, and Ischemia Assessment of the Parathyroid Gland Under Endoscopic Thyroid Surgery

Objective: This video demonstrates the use of PTAIR 2.0, which is an artificial intelligence model for the prediction, identification, and ischemia assessment of parathyroid glands in endoscopic thyroid surgery. Methods: PTAIR 2.0 is an artificial intelligence model for parathyroid gland recognition during surgery. In total, 1641 patients who underwent endoscopic thyroid surgery at our hospital from August 2012 to December 2021 were selected. YOLOX was used to train this version. The hindsight strategy was used for the labeling of parathyroid gland prediction data.1–3 Results: PTAIR achieved the AP50 values for the prediction, identification, and ischemia assessment of the parathyroid glands of 94.1%, 98.9%, and 92.1%, respectively. Conclusions: PTAIR, which was established through computer vision, provides a novel methodology for the prediction, identification, and ischemia assessment of parathyroid glands in endoscopic thyroid surgery. PTAIR can be used to detect parathyroid glands and provide decision-making in the autotransplantation of parathyroid glands in endoscopic thyroid surgery. Acknowledgments: On behalf of the PTAIR Research Group, Yi-Jian Li from Fuzhou University, Jun-Yi Huang and Chi-Peng Zhou from Fujian Medical University Union Hospital, and Jing Zheng from Zhangzhou Affiliated Hospital of Fujian Medical University have also contributed to this video. Si-Ying Lin, Meng-Yao Li, and Jia-Fan Yu contributed equally to this study and are considered co-first authors. PTAIR is a registered trademark of Fujian Medical University Union Hospital. All other authors have no conflicts of interest to disclose. Funding Information: This research was supported by the China Scholarship Council; the Joint Funds for the Innovation of Science and Technology, Fujian Province (Grant Nos. 2018Y9093, 2018Y0915, and 2018Y9018); sponsored by Fujian Provincial Health Technology Project (Grant Nos. 2019-CX-16 and 2018-CX-17). Runtime of video: 3 mins 23 secs An abstract based on this video was posted for presentation at the 2022 American Thyroid Association Annual Meeting.

Abstracts

Cancer ScienceVolume 114, Issue S1 p. 1-2317 AbstractsOpen Access Abstracts First published: 15 February 2023 https://doi.org/10.1111/cas.15742AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Volume114, IssueS1Special Issue: Abstracts of the 81st Annual Meeting of the Japanese Cancer Association; 2022 Sep 29 ‐ Oct 1; Yokohama, JapanFebruary 2023Pages 1-2317 RelatedInformation

Literature as an Exotic Substance in Pre-Modern Literate Societies

This text was written for the "Seminar: World Literature: Circulations Outside the Modern” organized by Alexander Beecroft and Galin Tihanov at the ACLA (online) meeting on April 11, 2021 (Annual Meeting of the American Comparative Literature Association).

Proceedings of the 69th Annual Meeting of the Japanese Group Dynamics Association

Proceedings of the 69th Annual Meeting of the Japanese Group Dynamics Association

Industry Update, October 2022.

Industry Update, October 2022.

Publication Rates of Podium Presentations from the Orthopedic Summit: Fellow Resident and Medical Student Annual Meeting 2019-2021

Purpose To determine the publication rate of presentations presented at the Orthopaedic Summit and Evolving Techniques (OSET) Fellow Resident and Medical Student Annual Meeting 2019-2021 Methods All presentations from the OSET annual meeting between 2019 -2021 were identified from the OSET’s official website and confirmed through review of the OSET Official Programs. The 2019 and 2021 meeting were in person and the 2020 meeting was virtual due to the COVID pandemic. This information was then used to direct a search on PubMed and Google Scholar database to determine if the presentation was associated with a publication since the meeting. Publishing information was entered into the database. Results For 2019-2021 there were a total of 227 presentations with 101 associated publications (45%). The highest rate of publications was 63% of presentations published in 2019, followed by 49% rate of publications in 2020, and 27% rate of publications in 2021. The presentations were published at an average of 8.1 months after presentation. Conclusion Our research demonstrated a 45% publication rate over a 3-year period of presentations presented at the OSET annual meetings. Our results are comparable to other publication rates for podium presentations in other societies (e.g. American Academy of Orthopaedic Surgeons, Annual Meeting of the Pediatric Orthopedic Society of North America, Orthopedic Trauma Association Annual Meeting, American Academy for Surgery of the Hand, Annual Meetings of the North American Spine Society, and American Orthopedic Society for Sports Medicine Annual Meeting). This validates the quality of research presented in podium presentations format at the OSET Annual Meeting.

Implications of Elevated Postprandial Glucose and Nutritional Approaches for Postprandial Glucose Management with a Focus on Whey Proteins

This symposium took place at the 58th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Stockholm, Sweden. The first speaker was John L. Sievenpiper, who discussed the pathophysiology of postprandial hyperglycaemia and how it may impact the risk of cardiovascular disease (CVD), peripheral vascular disease, insulin resistance, and other comorbidities in patients with Type 2 diabetes (T2D). Sievenpiper then reviewed various pharmacological interventions that target postprandial glucose (PPG) and insulin levels, including incretin therapies and α-glucosidase inhibitors, such as acarbose. Data presented showed that a low glycaemic index (GI) diet can improve glycaemic control and reduce cardiometabolic risk factors in patients with Type 1 diabetes (T1D) and T2D. Sievenpiper then presented data on novel non-pharmacological approaches that target PPG, including mulberry leaf (Morus alba L) extract (MLE), which has α-glucosidase inhibitor activity, reducing PPG and insulin responses to sucrose. The second speaker, Bo Ahrén, presented data on the effects of whey protein (WP) and branched-chain amino acids (BCAA) on PPG management and as a potential intervention for postprandial hyperglycaemia. They also discussed the mechanisms underlying the effects of WP, and highlighted data presented at the 2022 58th Annual EASD meeting by Johansen and colleagues on a novel micelle microgel technology. WP microgels (WPM) deliver highly concentrated and lower calorie doses of WP, with the potential to be developed clinically as therapeutics for T2D. The symposium concluded with a question and answer session between panel members and the audience. Ian J. Neeland was the meeting moderator.

Implications of Elevated Postprandial Glucose and Nutritional Approaches for Postprandial Glucose Management with a Focus on Whey Proteins

This symposium took place at the 58th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Stockholm, Sweden. The first speaker was John L. Sievenpiper, who discussed the pathophysiology of postprandial hyperglycaemia and how it may impact the risk of cardiovascular disease (CVD), peripheral vascular disease, insulin resistance, and other comorbidities in patients with Type 2 diabetes (T2D). Sievenpiper then reviewed various pharmacological interventions that target postprandial glucose (PPG) and insulin levels, including incretin therapies and α-glucosidase inhibitors, such as acarbose. Data presented showed that a low glycaemic index (GI) diet can improve glycaemic control and reduce cardiometabolic risk factors in patients with Type 1 diabetes (T1D) and T2D. Sievenpiper then presented data on novel non-pharmacological approaches that target PPG, including mulberry leaf (Morus alba L) extract (MLE), which has α-glucosidase inhibitor activity, reducing PPG and insulin responses to sucrose. The second speaker, Bo Ahrén, presented data on the effects of whey protein (WP) and branched-chain amino acids (BCAA) on PPG management and as a potential intervention for postprandial hyperglycaemia. They also discussed the mechanisms underlying the effects of WP, and highlighted data presented at the 2022 58th Annual EASD meeting by Johansen and colleagues on a novel micelle microgel technology. WP microgels (WPM) deliver highly concentrated and lower calorie doses of WP, with the potential to be developed clinically as therapeutics for T2D. The symposium concluded with a question and answer session between panel members and the audience. Ian J. Neeland was the meeting moderator.